4

OWNERSHIP DOCUMENT

Company: Atara Biotherapeutics, Inc.
Filed: May 16, 2025
Period of Report: May 16, 2025
Accession Number: 0001104659-25-050116

View Document ↗ View on SEC.gov ↗